Medtronic (MDT) Misses Q4 EPS by 5c, Offers Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- Wall St set for higher open as investors weigh Mideast negotiations
- Oil falls after US-Iran talks signal easing supply risks
- Intel soars after Trump says Apple agreed to work with chipmaker on US production
- Apple CEO warns price hikes 'unavoidable' as chip costs bite - WSJ
- Wall Street scrambles to lift Micron price targets ahead of earnings
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Needham Starts NeoVolta (NEOV) at Buy
- Companies to add 40 million barrels of oil to US SPR after Iran war ends, energy secretary says
- China makes small dent in deflation battle as supply-demand imbalance persists
- Sanuwave cuts Q2 2026 revenue guidance amid Ultramist sales pressure
Medtronic reports full year and fourth quarter fiscal year 2022 financial results; announces 8% dividend increase
May 26, 2022 6:46 AM EDTMid-single digit FY22 revenue growth; Q4 results affected by temporary global supply chain impacts and China lockdowns
DUBLIN, May 26, 2022 /PRNewswire/ -- Medtronic plc (NYSE: MDT) today announced financial results for its fourth quarter and fiscal year 2022, which ended April 29, 2022.
Key Highlights
FY22 revenue increased 5% reported and organicFY22 GAAP diluted EPS increased 40%; non-GAAP diluted EPS increased 26%FY22 cash flow from operations of $7.3 billion increased 18%; FY22 free cash flow of $6.0 billion increased 22%Quarterly dividend... More